Filing Details
- Accession Number:
- 0001415889-24-010571
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-09 16:30:10
- Reporting Period:
- 2024-04-05
- Accepted Time:
- 2024-04-09 16:30:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1106578 | A Martine Rothblatt | C/O United Therapeutics Corporation 1000 Spring Street Silver Spring MD 20910 | Chairperson & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-04-05 | 15,000 | $129.49 | 15,130 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-04-05 | 204 | $231.31 | 14,926 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-05 | 562 | $232.75 | 14,364 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-05 | 4,176 | $233.77 | 10,188 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-05 | 2,986 | $234.74 | 7,202 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-05 | 4,667 | $235.91 | 2,535 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-05 | 2,405 | $236.91 | 130 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-04-08 | 5,060 | $129.49 | 5,190 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-04-08 | 202 | $232.43 | 4,988 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-08 | 260 | $235.36 | 4,728 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-08 | 1,639 | $236.86 | 3,089 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-08 | 1,114 | $237.63 | 1,975 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-08 | 1,732 | $238.85 | 243 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-08 | 113 | $239.63 | 130 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options | Disposition | 2024-04-05 | 15,000 | $0.00 | 15,000 | $129.49 |
| Common Stock | Stock Options | Disposition | 2024-04-08 | 5,060 | $0.00 | 5,060 | $129.49 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 372,529 | 2014-12-31 | 2024-12-31 | No | 4 | M | Direct |
| 367,469 | 2014-12-31 | 2024-12-31 | No | 4 | M | Direct |
Footnotes
- This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.
- This transaction was executed in multiple trades at prices ranging from $231.14 to $231.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $232.16 to $233.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $233.20 to $234.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $234.21 to $235.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $235.39 to $236.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $236.57 to $237.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $232.04 to $232.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $235.03 to $235.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $236.19 to $237.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $237.19 to $238.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $238.325 to $239.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
